This compound is a chiral pharmaceutical intermediate used in the synthesis of ramelteon, a melatonin receptor agonist. It features a benzoxazole ring system with a chlorine substituent and an amine-containing side chain, which contribute to its role in constructing the active pharmaceutical ingredient.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1266975-27-2
(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-ium chloride
research compound
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one
pharmaceutical intermediate
1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-one
pharmaceutical intermediate
(1R,2R)-2-(3,4-Difluorophenyl)cyclopropanecarboxylic acid
pharmaceutical intermediate
1-(Fmoc-amino)cyclopropanecarboxylic acid
pharmaceutical intermediate
2-Bromo-6-methoxybenzaldehyde
pharmaceutical intermediate
5-Bromo-2-methoxy-6-picoline
pharmaceutical intermediate
1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone
pharmaceutical intermediate
5-chloro-2-[(5R)-5-methyl-1,4-diazepan-1-yl]-1,3-benzoxazole
RADJSLVGESASMK-SECBINFHSA-N
C[C@@H]1CCN(CCN1)C2=NC3=C(O2)C=CC(=C3)Cl
—